GT6

(2S,2'S)-N,N'-[(6,6'-difluoro-1H,1'H-2,2'-biindole-3,3'-diyl)bis{methanediyl[(2R,4S)-4-hydroxypyrrolidine-2,1-diyl][(2S)-1-oxobutane-1,2-diyl]}]bis[2-(methylamino)propanamide]


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2S,2'S)-N,N'-[(6,6'-difluoro-1H,1'H-2,2'-biindole-3,3'-diyl)bis{methanediyl[(2R,4S)-4-hydroxypyrrolidine-2,1-diyl][(2S)-1-oxobutane-1,2-diyl]}]bis[2-(methylamino)propanamide]
Identifiers(2S)-N-[(2S)-1-[(2R,4S)-2-[[6-fluoranyl-2-[6-fluoranyl-3-[[(2R,4S)-1-[(2S)-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-4-oxidanyl-pyrrolidin-2-yl]methyl]-1H-indol-2-yl]-1H-indol-3-yl]methyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]-2-(methylamino)propanamide
FormulaC42 H56 F2 N8 O6
Molecular Weight806.941
TypeNON-POLYMER
Isomeric SMILESCC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc2c3ccc(cc3[nH]c2c4c(c5ccc(cc5[nH]4)F)C[C@@H]6C[C@@H](CN6C(=O)[C@H](CC)NC(=O)[C@H](C)NC)O)F)O)NC(=O)[C@H](C)NC
InChIInChI=1S/C42H56F2N8O6/c1-7-33(49-39(55)21(3)45-5)41(57)51-19-27(53)15-25(51)17-31-29-11-9-23(43)13-35(29)47-37(31)38-32(30-12-10-24(44)14-36(30)48-38)18-26-16-28(54)20-52(26)42(58)34(8-2)50-40(56)22(4)46-6/h9-14,21-22,25-28,33-34,45-48,53-54H,7-8,15-20H2,1-6H3,(H,49,55)(H,50,56)/t21-,22-,25-,26-,27-,28-,33-,34-/m0/s1
InChIKeyPKWRMUKBEYJEIX-DXXQBUJASA-N

Chemical Details

Formal Charge0
Atom Count114
Chiral Atom Count8
Bond Count119
Aromatic Bond Count20

Drug Info: DrugBank

DrugBank IDDB11782 
NameBirinapant
Groups investigational
DescriptionBirinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
SynonymsBirinapant
Categories
  • Amino Acids, Peptides, and Proteins
  • Heterocyclic Compounds, Fused-Ring
  • Oligopeptides
  • Peptides
CAS number1260251-31-7

Related Resource References

Resource NameReference
Pharos CHEMBL3039522
PubChem 49836020
ChEMBL CHEMBL3039522